BR112022025216A2 - Administração de sulcardina para tratamento de fibrilação atrial aguda - Google Patents
Administração de sulcardina para tratamento de fibrilação atrial agudaInfo
- Publication number
- BR112022025216A2 BR112022025216A2 BR112022025216A BR112022025216A BR112022025216A2 BR 112022025216 A2 BR112022025216 A2 BR 112022025216A2 BR 112022025216 A BR112022025216 A BR 112022025216A BR 112022025216 A BR112022025216 A BR 112022025216A BR 112022025216 A2 BR112022025216 A2 BR 112022025216A2
- Authority
- BR
- Brazil
- Prior art keywords
- sulcardine
- administration
- treatment
- atrial fibrillation
- acute atrial
- Prior art date
Links
- SYZGIWXQGIBJGN-UHFFFAOYSA-N hbi-3000 Chemical compound C1=CC(OC)=CC=C1S(=O)(=O)NCC1=CC(CN2CCCC2)=C(O)C(CN2CCCC2)=C1 SYZGIWXQGIBJGN-UHFFFAOYSA-N 0.000 title abstract 2
- 206010003658 Atrial Fibrillation Diseases 0.000 title 1
- 230000001154 acute effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000005236 sound signal Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
MÉTODO E APARELHO DE ESTIMATIVA DE ATRASO DE SINAL DE ÁUDIO ESTÉREO, APARELHO DE CODIFICAÇÃO DE ÁUDIO E MEIO DE ARMAZENAMENTO LEGÍVEL POR COMPUTADOR. São fornecidas neste documento composições e métodos para administração de sulcardina a um sujeito que dela necessite.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063038664P | 2020-06-12 | 2020-06-12 | |
| PCT/US2021/037098 WO2021252959A1 (en) | 2020-06-12 | 2021-06-11 | Sulcardine administration for treatment of acute atrial fibrillation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112022025216A2 true BR112022025216A2 (pt) | 2023-04-04 |
Family
ID=78824214
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112022025216A BR112022025216A2 (pt) | 2020-06-12 | 2021-06-11 | Administração de sulcardina para tratamento de fibrilação atrial aguda |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11813245B2 (pt) |
| EP (1) | EP4164633A4 (pt) |
| JP (1) | JP2023529196A (pt) |
| KR (1) | KR20230024347A (pt) |
| CN (1) | CN116723836A (pt) |
| AU (1) | AU2021288056A1 (pt) |
| BR (1) | BR112022025216A2 (pt) |
| CA (1) | CA3182015A1 (pt) |
| CL (1) | CL2022003501A1 (pt) |
| CO (1) | CO2023000194A2 (pt) |
| IL (1) | IL298907A (pt) |
| MX (1) | MX2022015834A (pt) |
| WO (1) | WO2021252959A1 (pt) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1172908C (zh) * | 1999-12-10 | 2004-10-27 | 中国科学院上海药物研究所 | N-取代苄基或苯基芳香磺酰胺化合物及其用途 |
| CN1939298A (zh) | 2005-09-29 | 2007-04-04 | 中国科学院上海药物研究所 | 硫酸舒欣啶固体和靶向制剂及其制备方法 |
| ES2569123T3 (es) * | 2009-11-17 | 2016-05-06 | Huya Bioscience International Llc | Infusión lenta de sulcardina y sus sales |
| ES2644818T3 (es) * | 2009-11-17 | 2017-11-30 | Huya Bioscience International Llc | Tratamiento de fibrilación auricular |
| KR20180014778A (ko) | 2015-06-03 | 2018-02-09 | 트리아스텍 인코포레이티드 | 제형 및 이의 용도 |
| CA3023278C (en) | 2016-05-05 | 2019-04-30 | Triastek, Inc. | Controlled release dosage form |
| KR20230157528A (ko) | 2017-01-26 | 2023-11-16 | 트리아스텍 인코포레이티드 | 특정 위장 부위에서의 제어 방출의 투여 형태 |
| AU2019397511A1 (en) | 2018-12-13 | 2021-07-22 | Huyabio International, Llc | Sulcardine administration for treatment of acute atrial fibrillation |
| CA3128152A1 (en) * | 2019-01-29 | 2020-08-06 | Huya Bioscience International, Llc | Sulcardine salts |
-
2021
- 2021-06-11 JP JP2022575898A patent/JP2023529196A/ja active Pending
- 2021-06-11 BR BR112022025216A patent/BR112022025216A2/pt unknown
- 2021-06-11 IL IL298907A patent/IL298907A/en unknown
- 2021-06-11 WO PCT/US2021/037098 patent/WO2021252959A1/en active Application Filing
- 2021-06-11 KR KR1020237000723A patent/KR20230024347A/ko active Search and Examination
- 2021-06-11 EP EP21823026.6A patent/EP4164633A4/en active Pending
- 2021-06-11 MX MX2022015834A patent/MX2022015834A/es unknown
- 2021-06-11 CN CN202180055470.6A patent/CN116723836A/zh active Pending
- 2021-06-11 CA CA3182015A patent/CA3182015A1/en active Pending
- 2021-06-11 AU AU2021288056A patent/AU2021288056A1/en active Pending
- 2021-06-11 US US17/345,564 patent/US11813245B2/en active Active
-
2022
- 2022-12-09 CL CL2022003501A patent/CL2022003501A1/es unknown
-
2023
- 2023-01-10 CO CONC2023/0000194A patent/CO2023000194A2/es unknown
- 2023-10-11 US US18/484,823 patent/US20240058304A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023529196A (ja) | 2023-07-07 |
| EP4164633A4 (en) | 2024-07-31 |
| EP4164633A1 (en) | 2023-04-19 |
| CN116723836A (zh) | 2023-09-08 |
| US20210386708A1 (en) | 2021-12-16 |
| US20240058304A1 (en) | 2024-02-22 |
| MX2022015834A (es) | 2023-04-04 |
| CA3182015A1 (en) | 2021-12-16 |
| IL298907A (en) | 2023-02-01 |
| CL2022003501A1 (es) | 2023-06-09 |
| US11813245B2 (en) | 2023-11-14 |
| KR20230024347A (ko) | 2023-02-20 |
| CO2023000194A2 (es) | 2023-03-27 |
| WO2021252959A1 (en) | 2021-12-16 |
| AU2021288056A1 (en) | 2023-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024004332A (es) | Metodos de uso de inhibidores de ehmt2 para tratar o prevenir transtornos sanguíneos. | |
| BR112019000353A2 (pt) | método para o registro de uma transação de dados | |
| BR112016009209A8 (pt) | Método e aparelho para determinar uma matriz de decodificação para decodificar um sinal de áudio codificado, e meio de armazenamento legível por computador | |
| MX2019007234A (es) | Compuestos heterociclicos sustituidos con amina como inhibidores de ehmt2 y metodos de uso de los mismos. | |
| BR112018006098A2 (pt) | sistemas e métodos para processamento de vídeo | |
| BR112017007460A2 (pt) | inibidores de di-hidropirrolopiridina de ror-gama | |
| MA38399A1 (fr) | Formulation sous forme de comprimé, utile pour traiter l'insuffisance cardiaque aiguë et l'insuffisance cardiaque chronique | |
| BR112015019435A2 (pt) | codificador e decodificador de áudio com informações de programa ou metadados de estrutura de substream | |
| BR112017001420A2 (pt) | método | |
| BR112019013609A8 (pt) | Método e aparelho de processamento de informação | |
| WO2016033480A3 (en) | Intermediate compression for higher order ambisonic audio data | |
| BRPI1012014A8 (pt) | Método para preservar metadados durante uma operação de desfazer em um computador cliente, dispositivo de computação e meio de armazenamento legível por computador | |
| MX2018015302A (es) | Esteres de acidos grasos de cadena media de beta-hidroxibutirato y butanodiol y composiciones y metodos para usar los mismos. | |
| AR119158A1 (es) | Tratamientos de angioedema hereditario | |
| BR112017026743A2 (pt) | aparelho e método de decodificação, programa, e, aparelho e método de codificação | |
| BR112015007455A2 (pt) | método executável por dispositivo cliente para executar fluxo de mídia adaptativo tendo pluralidade de faixas de áudio e dispositivo de mídia player | |
| BR112015023439A2 (pt) | combinação de tratamentos de câncer utilizando micrornas e inibidores egfr-tki | |
| EP4389225A3 (en) | Cancer treatments using combinations of type 2 mek and erk inhibitors | |
| NZ748769A (en) | Nitroxyl donors with improved therapeutic index | |
| BR112018003042A2 (pt) | reutilização de sinal durante período de transição de largura de banda | |
| BR112015025919A2 (pt) | aparelho e método para o escalonamento do sinal do centro e o melhoramento estereofônico com base em uma relação sinal-para-downmix | |
| BR112014029458A2 (pt) | método e aparelho para avaliação de qualidade de mídia | |
| BR112014009910A2 (pt) | formulações de sal de meglumina de ácido 1-(5,6-dicloro-1h-benzo[d]imidazol-2-il)-1h-pirazol-4-carboxílico | |
| EP4242971A4 (en) | METHOD FOR GENERATING A VOLUME ANIMATION, COMPUTER READABLE RECORDING MEDIUM AND COMPUTER DEVICE | |
| BR112016028215A2 (pt) | obtenção de informação dispersa para renderizadores de áudio ambissônicos de ordem superior |